Autoimmune Diseases  >>  RSLV-132  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RSLV-132 / Resolve
NCT02194400: Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus

Checkmark Safety and tolerability data
Feb 2016 - Feb 2016: Safety and tolerability data
Completed
1
32
US
RSLV-132
Resolve Therapeutics
Systemic Lupus Erythematosus
11/15
11/15

Download Options